Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

Cholecalciferol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 20 USDMF, 15 CEP/COS, 2 JDMF, 2 EU WC, 3 NDC API, 19 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

FINISHED DOSAGE FORMULATIONS

699 FDF Dossiers, 6 FDA Orange Book, 412 Europe, 36 Canada, 6 South Africa, 239 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, TABLET;ORAL - EQ 70MG BASE;2,800 IU, TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

12 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 15 DKSH, 2 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 32 BASF, 1 Bioplus Life Sciences, 1 Clariant, 11 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 33 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 19 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 12 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

104 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 46 Thickeners and Stabilizers, 42 Direct Compression, 39 Taste Masking, 36 Solubilizers, 33 Controlled & Modified Release, 29 Granulation, 28 Parenteral, 26 Topical, 25 Film Formers & Plasticizers, 22 Co-Processed Excipients, 21 Disintegrants & Superdisintegrants, 19 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 13 Rheology Modifiers, 12 Emulsifying Agents, 9 Empty Capsules, 9 API Stability Enhancers, 6 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 24 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

376 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

76 APIs, 23 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 3 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/11/2024	DISHMAN NETHERLANDS B.V.	Netherlands	DISHMAN NETHERLANDS B.V. Veenendaal NL	R1-CEP 2007-347 - Rev 00	Cholecalciferol concentrate (oily form), 2 000 000 IU/g in arachis oil	2014-07-18	Valid	Chemical and TSE		575
28/11/2024	DISHMAN NETHERLANDS B.V.	Netherlands	DISHMAN NETHERLANDS B.V. Veenendaal NL	R1-CEP 2005-098 - Rev 03	Cholecalciferol	2012-02-07	Withdrawn by Holder	Chemical and TSE	2023-07-20	72

Cholecalciferol

Cholecalciferol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers

20 USDMF

15 CEP/COS

2 JDMF

2 EU WC

3 NDC API

19 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

6 Drugs in Development

FINISHED DOSAGE FORMULATIONS

699 FDF Dossiers

6 FDA Orange Book

412 Europe

36 Canada

6 South Africa

239 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

TABLET;ORAL - EQ 70MG BASE;2,800 IU

TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

12 Rochem International Inc

18 SPI Pharma

2 Seqens

15 DKSH

2 Pharm-RX Chemical

10 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

14 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

11 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

32 BASF

1 Bioplus Life Sciences

1 Clariant

11 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

2 Finar

11 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

33 Kerry

5 Kima Chemical

6 Lonza Capsugel

19 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

12 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

35 Roquette

16 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 The Dow Chemical Company

1 Ulanqab Kema New Material

1 Valens Pharmachem

3 Vasa Pharmachem

2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

104 Fillers, Diluents & Binders

57 Coating Systems & Additives